Aptar CSP Technologies launches fully integrated active packaging solution combining moisture adsorption and oxygen scavenging properties

  • Aptar CSP Technologies

Aptar CSP Technologies, a leader in material science and active packaging solutions that ensure product protection, extend shelf life and improve user experiences, and part of AptarGroup, Inc., announces the launch of the first-of-its kind combination oxygen scavenging and moisture adsorption active packaging solution. This new technology utilizes the company’s patented 3-phase Activ-Polymer™ platform within its Activ-Film™ product configuration.

This innovative combination technology builds on the recent U.S. FDA approval of an HIV prevention medicine expected to launch in Q1 2020 that utilizes the company’s Activ-Blister™ packaging solution to provide moisture adsorption and drug product stability.

Aptar CSP Technologies added the combined oxygen scavenging and moisture adsorption capability to the Activ-Film product to provide customers with a fully integrated solution for drug products that are sensitive to both moisture and oxidation. The unique proprietary formulation provides unparalleled dual protection in various packaging configurations, such as Activ-Blister, and broad application fields ranging from oral solid dose and transdermal to diagnostics and probiotics.

“This is an important milestone for Aptar CSP as we continue to expand the capabilities of our 3-phase Activ-Polymer platform technology to accelerate and de-risk the product development process, providing solutions that improve and save patients’ lives,” said Badre Hammond, Vice President Commercial Operations, Aptar CSP Technologies.

“This technology can help reduce packaging complexity while providing a custom solution to stability concerns, enabling pharmaceutical companies to enhance drug stability and support speed-to-market.”

Aptar CSP Technologies’ 3-phase Activ-Polymer platform technology offers customized active packaging solutions designed to meet the drug developer’s specific formulation as well as provide a broad spectrum of drug-specific protection, including aroma emitting, volatile organic compounds (VOCs) scavenging, and anti-microbial scavenging.

See also

Aptar CSP Technologies’ Activ-Blister™ Solutions Now Available for Manufacturing in the EMEA Region

Aptar CSP Technologies, part of AptarGroup, Inc. and a leader in active material science solutions to ensure product protection, extend shelf life and improve patient experience, announces a new manufacturing site able to produce its Activ-Blister™ Solutions for oral slide dose drugs in Europe. The move is part of a key strategic effort to expand production of Activ-Blister™ technology globally.

Aptar CSP presents 'rethinking oral solid dose packaging' webinar

Aptar CSP Technologies – a leader in active packaging solutions that ensure product protection, enhance brand recognition and improve use experiences, and part of AptarGroup Inc – is presenting its Activ-Blister Solutions for the protection of moisture and oxygen-sensitive tablets and capsules, alongside FreeThink Technologies and its ASAPprime technology for accelerated shelf-life determination. The combination is a “right the first time” approach to stability challenges and blister package design that virtually eliminates protracted testing and costly reformulations.

CSP Technologies' focus for enhancing the shelf life for transdermal and oral solid dose drugs

Despite being two very different drug delivery platforms, oral solid doses and transdermal patches can face similar packaging headspace challenges that impact shelf life; besides moisture and oxygen ingress, exposure to certain conditions can lead to the formation of volatile organic compounds (VOCs) and other gases that, in turn, may interact with drug products and capsules, adversely impacting their stability.

  • Jo Webb
  • Product Info
  • English
  • Created 31 Jan 2020
  • Modified 31 Jan 2020
  • Hits 1006